- Home
- CISS vs PTPI Comparison
CISS vs PTPI Comparison
Compare CISS & PTPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- PTPI
- Stock Information
- Founded
- CISS 2022
- PTPI 2020
- Country
- CISS Greece
- PTPI United States
- Employees
- CISS N/A
- PTPI N/A
- Industry
- CISS Marine Transportation
- PTPI Biotechnology: Pharmaceutical Preparations
- Sector
- CISS Consumer Discretionary
- PTPI Health Care
- Exchange
- CISS Nasdaq
- PTPI Nasdaq
- Market Cap
- CISS 3.0M
- PTPI 2.6M
- IPO Year
- CISS N/A
- PTPI N/A
- Fundamental
- Price
- CISS $0.58
- PTPI $0.07
- Analyst Decision
- CISS
- PTPI
- Analyst Count
- CISS 0
- PTPI 0
- Target Price
- CISS N/A
- PTPI N/A
- AVG Volume (30 Days)
- CISS 80.0K
- PTPI 95.8M
- Earning Date
- CISS 05-27-2025
- PTPI 05-14-2025
- Dividend Yield
- CISS N/A
- PTPI N/A
- EPS Growth
- CISS N/A
- PTPI N/A
- EPS
- CISS N/A
- PTPI N/A
- Revenue
- CISS $42,296,101.00
- PTPI $5,112,043.00
- Revenue This Year
- CISS N/A
- PTPI N/A
- Revenue Next Year
- CISS N/A
- PTPI $0.76
- P/E Ratio
- CISS N/A
- PTPI N/A
- Revenue Growth
- CISS 47.17
- PTPI N/A
- 52 Week Low
- CISS $0.48
- PTPI $0.05
- 52 Week High
- CISS $13.50
- PTPI $1.00
- Technical
- Relative Strength Index (RSI)
- CISS 30.12
- PTPI 40.73
- Support Level
- CISS $0.48
- PTPI $0.06
- Resistance Level
- CISS $0.74
- PTPI $0.11
- Average True Range (ATR)
- CISS 0.05
- PTPI 0.02
- MACD
- CISS 0.00
- PTPI 0.00
- Stochastic Oscillator
- CISS 37.27
- PTPI 8.24
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.